July 26, 2017 |
St. Jude Medical Inc. Announces Data to be Presented
October 25, 2016  | 
St. Paul, MN - St. Jude Medical, Inc. (NYSE:STJ), the global medical device company, announced that it will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics educational meeting in Washington, D.C., October 29 – November 2. Throughout the congress, the company will also feature its latest cardiovascular innovations, including PressureWire™ X guidewire, the latest generation of the pioneering PressureWire guidewire system; structural heart solutions and the CardioMEMS™ HF System. 
 
Three late-breaking or first report investigation sessions and one oral abstract presentation will highlight data from St. Jude Medical advancements in vascular and structural heart technologies.

Three late-breaking or first report investigation sessions and one oral abstract presentation will highlight data from St. Jude Medical advancements in vascular and structural heart technologies.

  • A comparison of stent visualization technologies for use during percutaneous coronary intervention (PCI) – Data from the first randomized clinical trial to compare OCT-guided, IVUS-guided and angiography-guided PCI

The session: “ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs. IVUS-Guided vs. Angio-Guided Stent Implantation in Patients with Coronary Artery Disease,” will be presented by Dr. Ziad A. Ali, associate director of translational medicine at the Center for Interventional Vascular Therapy at Columbia University Medical Center in New York at 9 a.m. on Sunday, October 30. This is the first late-breaking clinical trial presentation of TCT 2016. Continue>

Page | 1 2 3
Suggested Articles